5‐Aminoimidazole‐4‐Carboxamide‐1‐β‐4‐Ribofuranoside Stimulates Tyrosine Hydroxylase Activity and Catecholamine Secretion by Activation of AMP‐Activated Protein Kinase in PC12 Cells
- 6 July 2007
- journal article
- Published by Wiley in Journal of Neuroendocrinology
- Vol. 19 (8) , 621-631
Abstract
The activity of AMP‐activated protein kinase (AMPK) is regulated by the metabolic and nutritional state of the cell. 5‐Aminoimidazole‐4‐carboxamide‐1‐β‐4‐ribofuranoside (AICAR) is transformed into riboside monophosphate (ZMP) via phosphorylation by adenosine kinase inside the cell and exerts it effect by stimulating AMPK. AICAR significantly induces an increase in AMPK activity in a dose‐ and time‐dependent manner in the rat pheochromocytoma cell line PC12. In addition, compound C, an AMPK inhibitor, as well as 5′‐amino‐5′‐dAdo, an adenosine kinase inhibitor, inhibits the AICAR‐induced AMPK activity. AICAR significantly stimulates tyrosine hydroxylase (TH) (the rate‐limiting enzyme in the biosynthesis of catecholamine) activity and the corresponding mRNA level, which closely matches with the TH protein level. In addition, AICAR provokes a rapid and long‐lasting increase in the phosphorylation of TH at Ser19, Ser31 and Ser40. AICAR also markedly activates ERKs, JNK and p38. The MEK‐1‐inhibitor (PD‐098059) causes a partial, but significant, inhibition of AICAR‐induced TH enzyme activity by phosphorylation of Ser31 without affecting phosphorylation at the two other sites. By contrast, neither the JNK‐inhibitor nor the p38‐inhibitor affects TH enzyme activity and phosphorylation. Similarly, PD‐098059 partially, but significantly, inhibits the AICAR‐induced increase in the TH mRNA level. Furthermore, AICAR increases the level of cAMP in PC12 cells. The present study also shows that H89, a protein kinase A inhibitor, abolishes the AICAR‐induced increase in the level of TH mRNA, as well as the corresponding enzyme activity and Ser40 phosphorylation. Finally, AICAR significantly increases dopamine secretion from PC12 cells. These findings indicate that AICAR activates catecholamine synthesis and secretion through AMPK activation in chromaffin cells.Keywords
This publication has 51 references indexed in Scilit:
- Developing a head for energy sensing: AMP‐activated protein kinase as a multifunctional metabolic sensor in the brainThe Journal of Physiology, 2006
- 5-Aminoimidazole-4-Carboxamide-1-β-4-Ribofuranoside Inhibits Proinflammatory Response in Glial Cells: A Possible Role of AMP-Activated Protein KinaseThe Journal of Neuroscience, 2004
- Effects of Stimulation of AMP-activated Protein Kinase on Insulin-like Growth Factor 1- and Epidermal Growth Factor-dependent Extracellular Signal-regulated Kinase PathwayJournal of Biological Chemistry, 2001
- κ‐Opioid inhibits catecholamine biosynthesis in PC12 rat pheochromocytoma cellFEBS Letters, 2000
- Isoform-specific Purification and Substrate Specificity of the 5′-AMP-activated Protein KinaseJournal of Biological Chemistry, 1996
- Activation of glycogen phosphorylase and glycogenolysis in rat skeletal muscle by AICAR — an activator of AMP‐activated protein kinaseFEBS Letters, 1996
- Mammalian AMP-activated Protein Kinase SubfamilyJournal of Biological Chemistry, 1996
- 5′‐AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP‐activated protein kinase. Studies using bacterially expressed human protein phosphatase‐2Cα and native bovine protein phosphatase‐2AcFEBS Letters, 1995
- Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell‐permeable activator of AMP‐activated protein kinaseFEBS Letters, 1994
- Evidence that AMP triggers phosphorylation as well as direct allosteric activation of rat liver AMP‐activated protein kinaseEuropean Journal of Biochemistry, 1991